[Insulin aspart].
Namba
Mitsuyoshi
M
Division of Diabetes and Metabolism, Department of Internal Medicine, Hyogo Medical College.
D001786:Blood Glucose / Q000378:metabolism; D017326:Clinical Trials, Phase III as Topic; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy*; D005060:Europe; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D007328:Insulin / Q000008:administration & dosage* / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D061267:Insulin Aspart; D007332:Insulin Infusion Systems; D007564:Japan; D014481:United States
D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin; D061267:Insulin Aspart